From medical scribes to clinical trial platforms, AI-driven solutions are key targets of digital health M&A deals in 2024 so far. Here’s where we’re seeing the most activity.
Health tech unicorn Commure recently announced it would acquire AI medical scribe platform Augmedix for $139M.
This acquisition follows Commure’s Oct 2023 acquisition of another AI-driven provider workflow solution Athelas — which offers revenue cycle management (RCM) and automated documentation services — further bolstering its AI arsenal.
These deals reflect a key trend in healthcare M&A: AI is all the rage.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
